The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Full text access
Eficacia del tratamiento con eritropoyetina humana recombinante (EPO-Hur) en niños anémicos con insuficiencia renal crónica (IRC). Experiencia de siete meses
Visits
5641
M. Navarro, A. Alonso, J. Mª. Avila, E. Herrero y C. garcía Medeguer.
This item has received
Article information
Full text is only available in PDF




